Laboratory

Discover our products

Clinical

Discovers our solutions

TGen and ABL pursue global rollout of advanced TB test

Mar 19, 2019

FLAGSTAFF, Ariz., LUXEMBOURG City, Luxembourg — In an important step toward eradicating tuberculosis (TB), the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has signed a licensing agreement with an international biomedical firm, Advanced Biological Laboratories (ABL…
Read more
Advanced Biological Laboratories, Mayo Clinic Laboratories collaborate on test development to help patients with cytomegalovirus infection

Mar 14, 2019

LUXEMBOURG VILLE, Luxembourg, and ROCHESTER, Minn. – Advanced Biological Laboratories (ABL), S.A., a Luxembourg-based diagnostics company and leader in virology genotyping, and Mayo Clinic Laboratories have announced a collaboration. The two organizations are working together to develop a clinical t…
Read more
IntegraGen and Advanced Biological Laboratories sign global licensing agreement for the commercialization of miRpredX test

Mar 04, 2019

ÉVRY, France and LUXEMBOURG City, Luxembourg (February 27th, 2019) – IntegraGen, a company specializing in the transformation of data from biological samples into genomic information and diagnostic tools for oncology, and Advanced Biological Laboratories (ABL), a leading integrated diagnostics…
Read more

Early access program launched on ABL Life Science products!

Jan 11, 2019

ABL launches its Life Science division and starts the distribution of disruptive molecular biology instruments to be used for research purposes – Join our Early Access Program and get 30% discount on all UltraGene real time PCR systems! More information Join the program
Read more
ABL Announces Distribution Agreement with ILC – Instrumentos de Laboratório e Científicos Lda in Portugal

Jan 07, 2019

Advanced Biological Laboratories (ABL) S.A. and ILC – Instrumentos de Laboratório e Científicos Lda are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Portugal. See current ch…
Read more
ABL and Xi’an Tianlong Science and Technology Co., Ltd announce a distribution agreement conferring to ABL the ability to commercialize innovative real-time amplification (qPCR) instruments and reagents as well as RNA/DNA automated extraction solutions

Dec 27, 2018

LUXEMBOURG VILLE, Luxembourg, December 27th, 2018 — Advanced Biological Laboratories (ABL) S.A. today announced the official launch of its Life Science division to provide on a worldwide basis, innovative solutions around molecular biology. It is also proud to announce the execution of a distr…
Read more

ABL Announces Distribution Agreement with ELTA 90 Medical Science in Serbia & Montenegro

Nov 30, 2018

Advanced Biological Laboratories (ABL) S.A. and ELTA 90 Medical Science are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Serbia and Montenegro. See current channel partners.
Read more
New poster on HIV resistance to be presented at the HIV DART 2018 congress

Oct 29, 2018

We are pleased to announce that a new poster communication entitled “Clinical resistance to dolutegravir assessed by next-generation sequencing in patients pre-exposed to raltegravir” will be presented at the HIV DART and Emerging Viruses 2018 congress in Miami (USA, 27-29 November 2018)…
ABL Announces Distribution Agreement with Bio-Active Co., Ltd. in Thailand

Oct 25, 2018

Advanced Biological Laboratories (ABL) S.A. and Bio-Active Co., Ltd. are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Thailand. See current channel partners.
Read more